AstraZeneca PLC (AZN) stock
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
AstraZeneca's pe ratio was 50.1× on Oct 19, 2026, against 73.2× a year earlier. Over the last 5 years it ranged from 46.9× to 138.8×, with a median of 71.0×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 50.1× | −31.6 |
| 2025 | Dec 31, 2025 | 81.7× | +12.9 |
| 2024 | Dec 31, 2024 | 68.8× | −58.9 |
| 2023 | Dec 29, 2023 | 127.7× | +78.8 |
| 2017 | Jan 31, 2017 | 48.8× | −0.2 |
| 2016 | Dec 30, 2016 | 49.0× | – |
See a number that looks wrong?